ストックスクリーナーアプリを入手
36.12
1.91%
-0.705
アフターアワーズ：
36.10
-0.025
-0.07%
前日終値:
$36.83
開ける：
$36.94
24時間の取引高:
1.44M
Relative Volume:
0.67
時価総額：
$5.73B
収益：
$264.79M
当期純損益:
$-14.36M
株価収益率:
-328.41
EPS:
-0.11
ネットキャッシュフロー:
$-28.11M
1週間 パフォーマンス:
+1.56%
1か月 パフォーマンス:
+23.17%
6か月 パフォーマンス:
-8.38%
1年 パフォーマンス:
+54.45%
1日の値動き範囲:
$35.95
$37.11
1週間の範囲:
$34.52
$37.15
52週間の値動き範囲:
$21.16
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
名前
Tg Therapeutics Inc
セクター
電話
(212) 554-4484
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
36.12 | 5.84B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2024-10-29 | 開始されました | TD Cowen | Buy |
| 2023-08-02 | アップグレード | Goldman | Sell → Neutral |
| 2023-06-26 | 再開されました | Jefferies | Buy |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
| 2021-04-20 | 開始されました | Goldman | Neutral |
| 2021-04-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-01 | 開始されました | JP Morgan | Overweight |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | 開始されました | Evercore ISI | Outperform |
| 2020-01-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-02-06 | 再開されました | Jefferies | Buy |
| 2018-09-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 再開されました | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 再開されました | H.C. Wainwright | Buy |
| 2017-04-25 | 開始されました | Jefferies | Buy |
| 2017-03-06 | 繰り返されました | FBR & Co. | Outperform |
| 2016-10-06 | 再開されました | Brean Capital | Buy |
| 2016-05-27 | 開始されました | SunTrust | Buy |
| 2015-12-01 | 開始されました | FBR Capital | Outperform |
| 2015-09-09 | 開始されました | Raymond James | Strong Buy |
| 2015-08-12 | 再開されました | H.C. Wainwright | Buy |
| 2015-06-19 | 繰り返されました | Brean Capital | Buy |
| 2014-12-11 | 繰り返されました | ROTH Capital | Buy |
| 2014-12-10 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tg Therapeutics Inc (TGTX) 最新ニュース
What TG Therapeutics, Inc.'s (NASDAQ:TGTX) 26% Share Price Gain Is Not Telling You - simplywall.st
Can TG Therapeutics Inc. stock rebound after recent weakness2025 Market Sentiment & AI Optimized Trade Strategies - newser.com
Key metrics from TG Therapeutics Inc.’s quarterly dataSwing Trade & Accurate Intraday Trading Signals - newser.com
TG Therapeutics, Inc. (TGTX) Investor Outlook: Strong Revenue Growth and Promising Pipeline Signal Potential Upside - DirectorsTalk Interviews
TG Therapeutics, Inc. (TGTX) Investor Outlook: Riding On A 92.10% Revenue Growth Wave - DirectorsTalk Interviews
What makes TG Therapeutics Inc. (NKB2) stock appealing to growth investorsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
TG Therapeutics (TGTX) Slashes 18% on Lower 2025 Sales Guidance - MSN
What drives TG Therapeutics Inc stock priceGlobal Trade Effects & Low Risk Capital Growth Plans - earlytimes.in
Is TG Therapeutics Inc a good long term investmentHead and Shoulders Patterns & Demo Trading Rooms Open Daily - Early Times
What analysts say about TG Therapeutics Inc stockStock Valuation Metrics & Backtest Your Strategy Before You Risk Money - earlytimes.in
How risky is TG Therapeutics Inc. (NKB2) stock compared to peers2025 Historical Comparison & Advanced Swing Trade Entry Plans - newser.com
Tg Therapeutics And Ke Holdings Top The Bull Strangle Watch List For This Week - Barchart.com
TG Therapeutics’ MS drug shows low relapse rate after six years By Investing.com - Investing.com South Africa
TG Therapeutics’ MS drug shows low relapse rate after six years - Investing.com Australia
TGTX Shares Rise on Promising Six-Year Data from ULTIMATE Trials - GuruFocus
TG Therapeutics Says 6-Year Briumvi Data Show 90% of Multiple Sclerosis Patients Free From Progression - MarketScreener
TG Therapeutics Reports Six-Year Data for BRIUMVI® Showing Exceptional Efficacy and Consistent Safety Profile in Multiple Sclerosis Treatment - Quiver Quantitative
New Data for BRIUMVI® Demonstrate 89.9% of Patients with - GlobeNewswire
Breakthrough: MS Drug Keeps 90% of Patients Disability-Free for 6 YearsTG Therapeutics' BRIUMVI Sets New Bar - Stock Titan
TG Therapeutics Hits Day High with Strong 8.03% Intraday Surge - Markets Mojo
19,900 Shares in TG Therapeutics, Inc. $TGTX Bought by Strs Ohio - MarketBeat
TG Therapeutics (TGTX): Evaluating Valuation After New Phase 3 BRIUMVI Trial Launch - Sahm
What is B. Riley's Estimate for TG Therapeutics Q3 Earnings? - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $55.00 - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Bull Run: Can TG Therapeutics Inc maintain sales growthMarket Growth Summary & Low Risk Profit Maximizing Plans - خودرو بانک
Strs Ohio Makes New Investment in TG Therapeutics, Inc. $TGTX - Defense World
What is B. Riley's Estimate for TG Therapeutics Q4 Earnings? - MarketBeat
Voya Investment Management LLC Has $11.85 Million Position in TG Therapeutics, Inc. $TGTX - MarketBeat
What is B. Riley’s Forecast for TG Therapeutics Q4 Earnings? - Defense World
Day Trade: Will TG Therapeutics Inc outperform tech stocksWeekly Trend Report & Weekly Stock Breakout Alerts - خودرو بانک
Short Squeeze: Should you avoid ProShares Trust ProShares Ultra Materials stock right now2025 Volume Leaders & Reliable Volume Spike Trade Alerts - khodrobank.com
B. Riley Has Bearish Outlook for TG Therapeutics Q3 Earnings - Defense World
Market Review: What are TG Therapeutics Incs recent SEC filings showingEarnings Overview Report & Daily Entry Point Alerts - khodrobank.com
Institution Moves: Does TG Therapeutics Inc stock benefit from AI growth2025 Fundamental Recap & Weekly Return Optimization Alerts - khodrobank.com
TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $55.00 at B. Riley - Defense World
Intech Investment Management LLC Increases Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
Sentiment Review: Can TG Therapeutics Inc. sustain its profitabilityWeekly Investment Recap & AI Forecast for Swing Trade Picks - khodrobank.com
TG Therapeutics rises 17% as 2025 revenue guidance, Q4 revenue beats expectations - MSN
TGTX: B. Riley Securities Raises Price Target on TG Therapeutics - GuruFocus
How cyclical is TG Therapeutics Inc.’s revenue streamWeekly Stock Recap & Free Risk Controlled Daily Trade Plans - خودرو بانک
B. Riley Raises Price Target on TG Therapeutics to $55 From $53, Keeps Buy Rating - MarketScreener
Focus Partners Wealth Boosts Stock Holdings in TG Therapeutics, Inc. $TGTX - Defense World
Quarterly Trades: Is TG Therapeutics Inc undervalued by DCF analysis2025 Macro Impact & Weekly High Return Stock Forecasts - خودرو بانک
TG Therapeutics (NASDAQ:TGTX) Director Sagar Lonial Sells 20,852 Shares - MarketBeat
Bull Bear: Is Urgent.ly Inc. a potential multi baggerRate Hike & Daily Profit Maximizing Tips - خودرو بانک
Will TG Therapeutics Inc benefit from AI trends2025 Key Lessons & Weekly High Return Stock Forecasts - خودرو بانک
Weekly Earnings: Can TG Therapeutics Inc maintain sales growth2025 Trade Ideas & AI Driven Price Forecasts - khodrobank.com
Woodline Partners LP Makes New Investment in TG Therapeutics, Inc. $TGTX - MarketBeat
Signal Recap: Is TG Therapeutics Inc. currently under institutional pressureJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - khodrobank.com
Aug Macro: How cyclical is TG Therapeutics Incs revenue streamJuly 2025 Selloffs & Reliable Momentum Entry Alerts - خودرو بانک
Tg Therapeutics Inc (TGTX) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):